AmbrogioLab

Pls RT: Are you studying the multifaceted MAPK pathway? We would love to hear about your exciting research! Abstract Deadline 👉16.12.2024 for the #virtualmeeting on "Drugging and regulating the #MAPKpathway" organised with @EACRnews with @Boehringer eacr.org/conference/boe…

📖 🎯 A new book! RAS Drug Discovery • Past, Present and Future 🔸️ A comprehensive overview of the state-of-the-art medicinal chemistry approaches towards targeting the formerly undruggable oncogene, KRAS. @Aiims1742 @AndresFCardonaZ @FredNatLab @Tony_Calles @chulkimMD @CentralParkWMD @StephenVLiu @BenjaminBesseMD @EricTopol @gerlach_d @ArndtVogel @RonDePinho @DrYukselUrun @DavidHongMD @CadranelJ @pashtoonkasi @ChadPecot @JacobAdashek @AmbrogioLab 🔸️ shop.elsevier.com/books/ras-drug…

I am excited for the next three days of @theNCI's RAS Initiative Symposium 2024. Today, @NCIDirector Rathmell and AACR Past President Frank McCormick kicked off this important meeting aimed at mobilizing the cancer research community to target RAS-driven cancers.

Excited to co-organize the virtual @EACRnews @Boehringer Conference: Drugging & Regulating the MAP Kinase Pathway! Submit an abstract or join us. Please RT and share with others. Details & registration: eacr.org/conference/boe…

Our latest publication online now! rdcu.be/dSvhN @NatureComms Amazing team work @lab_santamaria @MJNokin @BiagioRicciutMD @DrMarkAwad @NadalErnest @cereda_lab

Happy to share our new publication on redox sensitivities of drug persistent and resistant BRAF mutated lung cancer. @GIGA_ULiege @iecb_bordeaux @ciccancer @lab_santamaria @AmbrogioLab @frsFNRS @televie @FondationLeon cell.com/cell-reports-m…

Our PREDICT project is among the 2024 ERC Proof of Concept grants! @ERC_Research #ERCPoC

EACR-@Mark Foundation Postdoctoral Fellowships are awarded for a period of three years and support excellent postdoctoral researchers in laboratories throughout Europe. Is that you? 👀 Apply by 21 August: eacr.org/eacr-fellowshi…

Mariano Barbacid receive the Mike Price Award ⁦@EACRnews⁩ #EACR2024 👏🏻👏🏻

There are just a few more days left to register for our upcoming Early-Career Researchers' Conference, happening online 25-26 June! 👉 Don't miss the 12 June deadline: eacr.org/conference/ear…

Stunning results from @CanaudLab who just presented their case study that led to an FDA-approved drug. Thanks @unito for organizing it! #research #24May

There's not long left to wait until the EACR Congress comes to the Netherlands in June! ☀️ Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 29 April. 2024.eacr.org

Read the #CancerHallmarks Perspective— Piecing the Puzzle Together. bit.ly/3JnQwuv @AmbrogioLab @MariaPAlcolea @gemmakelly_1 @waileongtam @theLundLab @alpcorreia @CJHPhD @IngunnStromnes @DanielaQuail @ErnstAurelie @DirenaAC @ShemaEfrat @BullmanLab @Marcus_Ruscetti

@iannaconelab Congrats Matteo!!

🎉Thrilled to announce that our project on reprogramming immune cells to fight chronic hepatitis B has been honored with an ERC Advanced Grant #ERCAdG! Our grant aims to redefine liver immunology and transform our battle against viral infections. 🧬💡 I'm deeply grateful to both current and past members of our lab for their exceptional dedication and hard work. It's truly thanks to their collective effort that we have been able to achieve such significant results. Equally, if not more, proud of my former PhD students @MarcoDegiov89, @inversodonato, and @ValeFuma91 for securing their own ERC grants (StG, CoG, and SyG, respectively) in the same call. 🌟 Stay tuned for groundbreaking insights! 🚀 #ScienceTwitter @ERC_Research @SanRaffaeleMI @MyUniSR europa.eu/!TkwhWc

Can you believe we got to fund 9 LS1 @ERC_research grants?!?🤩HUGE congratulations to:@clausen_lab, @Archaellum,T. Hoppe @CECAD_ , @Tampe_Lab, Y. Senis @Inserm, M. Glickman @BiologyTechnion, M. Foiani @IFOMresearch, @photosyn_Adam & @hecklab! Amazing&very diverse set of projects!

Just published with the #AACR24 presentation in Attacking #KRAS Beyond G12C: Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers, by Jingjing Jiang, Zhengping Wang, Mallika Singh et al. bit.ly/3vNIQ1A #RevolutionMedicines

@BiagioRicciutMD from @DanaFarber is presenting today at #AACR2024 section 41 poster 18 new data on wild type KRAS amplification as a de novo oncogenic driver in NSCLC. Terrific work done in collaboration with @AmbrogioLab. @DrMarkAwad @KRASKickers

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy | Nature #AACR24 nature.com/articles/s4158…

Out in @Nature concurrent with #AACR24 Two papers on biochemistry and preclinical characterization of Revolution Medicines’ RAS(ON) multiRAS inhibitor, with a focus on #PancreaticCancer @KenOliveLab @BenStanger01 @derlabunc nature.com/articles/s4158… nature.com/articles/s4158…

@DirenaAC @CD_AACR @IRBBarcelona @MSKCancerCenter @LoweLabMSKCC @msmelanoma Congrats Direna!! 👏🏻👏🏻👏🏻

Honored to receive the Inaugural Cancer Discovery Early Career Award. Thank you @CD_AACR for this recognition, which I extend to my many GREAT #colleagues and #mentors I've had the privilege to work with & learn from. @IRBBarcelona @MSKCancerCenter @LoweLabMSKCC @msmelanoma